By the Sick Economist   The mercury is high and you could fry an egg on the sidewalk. No...

  What, exactly, separates a biotech company from a “Big Pharma” company? What are the attributes that make each kind...

By Sudheer Narasimha, Equity Analyst    There are many Biotech stocks to consider when someone thinks about purchasing. However, in...

Twist Biosciences specializes in a kind of industrial production that would have been unimaginable just a few decades ago: the...

  After decades of nothing but frustration, 2023 has been a watershed year in the battle against Alzheimer's Disease. The...

  By Joshua Mazher, Equity Analyst   Navigating businesses in a post-pandemic world has been rocky, to say the least....

By Nathaniel Suryabudi, Equity Analyst    Recursion Pharmaceuticals is a cutting-edge biotechnology company that combines artificial intelligence, machine learning, and...

Slowly succumbing to blindness is one of the greatest fears that confronts today's senior citizens. Treatments for age related macular...

Curing cancer is not easy. It's a long, expensive road for even the most bold scientists and investors. In today's...